Eugene Schneider
Chief Tech/Sci/R&D Officer bei IONIS PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Zurzeit bekleidet Eugene Schneider die Position des Chief Clinical Development Officer & Executive VP bei Ionis Pharmaceuticals, Inc. Dr. Schneider ist außerdem Medical Director & VP-Behavioral Health bei Excellus BlueCross BlueShield. In der Vergangenheit war Dr. Schneider Senior Medical Director bei Biovail Technologies Ltd. und Senior Medical Director bei Synageva BioPharma Corp. Er erhielt einen Doktortitel von der University of Medicine & Dentistry of New Jersey.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
02.02.2024 | 49 812 ( 0,03% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Eugene Schneider
Unternehmen | Position | Beginn |
---|---|---|
IONIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Excellus Health Plan, Inc.
Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Eugene Schneider
Unternehmen | Position | Ende |
---|---|---|
Biovail Technologies Ltd. | Chief Tech/Sci/R&D Officer | - |
SYNAGEVA BIOPHARMA CORP | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Eugene Schneider
University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Excellus Health Plan, Inc.
Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Health Services |
Biovail Technologies Ltd. | |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |